CRISPR Medicine News

CRISPR Medicine News

About CRISPR Medicine News

Welcome to CRISPR Medicine News.
We are a global independent online media writing about gene therapy and genome editing.
Read more.

CLINICAL TRIALS
Indicator
IND Enabling
Phase I
Phase II
Phase III
Phenylketonuria, PKU, (NCT04768348)
Sponsors:
Homology Medicines, Inc
IND Enabling
Phase I
Phase II
Phase III
Mucopolysaccharidosis II, MPS II, (NCT05238324)
Sponsors:
Homology Medicines, Inc
Indicator
IND Enabling
Phase I
Phase II
Phase III
View all clinical trials
CRISPR Medicine News
Harvard Medical School (@HMS)

Genome Engineering Seminar Series (GESS)

Read more...Harvard Medical School (@HMS)
Join WDC Chat Community
WDC Chat Community
close
Search CRISPR Medicine